HEALTHSEATTLE TIMES
First human trial of Bundibugyo Ebola vaccine begins
The first clinical trial of a vaccine targeting the Bundibugyo strain of Ebola has begun, marking a milestone in efforts to contain the outbreak in central Africa.
Related Signal
Adjacent reporting
- First-ever AI-designed vaccine reaches human trials
- Ebola treatment trial begins in DRC, WHO says
- World's-first AI-designed vaccine successfully tested in humans
- AI-designed 'universal vaccine' passes first human clinical trial, could prevent future pandemics
- Ebola vaccine for Bundibugyo strain could take months before human trials
- Ebola vaccine made in UK now ready for trials